Management of Diffuse Low-Grade Glioma: The Renaissance of Robust Evidence

The surgical management of diffuse low-grade gliomas (DLGGs) has undergone a paradigm shift toward striving for maximal safe resection when feasible. While extensive observational data supports this transition, unbiased evidence in the form of high quality randomized-controlled trials (RCTs) is lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Brar, Karanbir, Hachem, Laureen D., Badhiwala, Jetan H., Mau, Christine, Zacharia, Brad E., de Moraes, Fabio Ynoe, Pirouzmand, Farhad, Mansouri, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560299/
https://www.ncbi.nlm.nih.gov/pubmed/33117714
http://dx.doi.org/10.3389/fonc.2020.575658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560299/
https://www.ncbi.nlm.nih.gov/pubmed/33117714
http://dx.doi.org/10.3389/fonc.2020.575658

Ejemplares similares